Studies in rheumatoid factors (RF) in sera of patients with hepatic diseases —comparison with rf in rheumatoid arthritis serum—
Yasumi Katsuta(Tokyo Medical University), Yoshihisa Nakazawa(Tokyo Medical University), Hirayuki Enomoto(Hyogo Medical University), Takahiro Masuda(Jichi Medical University), Shigetaka Shimizu, S. Hirose(Tokyo Medical University)
Cited by 0
Related Papers
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2–/– Mice by RANKL Transgene
|Journal of Biological Chemistry|2003|163
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
|American Journal of Physiology-Renal Physiology|2012|158
Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis
|Ultrasound in Medicine & Biology|2019|146